In addition, a pan-cancer analysis manifested that MS4A7 mRNA levels were widely elevated across numerous cancers, including esophageal carcinoma (ESCA), kidney chromophobe (KICH), acute myeloid leukemia (LAML), kidney renal clear cell carcinoma (KIRC), pancreatic adenocarcinoma (PAAD) and skin cutaneous melanoma (SKCM) (Additional file 1: Fig. S2B). This evidence concerns the gene MS4A7 and pancreatic adenocarcinoma.